Related Experiment Video
Updated: Aug 9, 2026

07:30
Surgical Technique for Superior Cervical Ganglionectomy in a Murine Model
Published on: December 2, 2022
[Neck Dissection for salivary gland carcinoma]
1Department of Otolaryngology, Yamada Red Cross Hospital, Mie.
Nihon Jibiinkoka Gakkai Kaiho
|September 24, 1998
Summary
Prophylactic neck dissection for high-grade salivary gland cancers did not improve local-regional control. Total neck dissection is recommended only for clinically positive necks, with supraomohyoid neck dissection feasible for submandibular gland cancer without lymph node metastasis.
Area of Science:
- Oncology
- Head and Neck Surgery
- Surgical Pathology
Background:
- High-grade salivary gland malignancies present a complex treatment challenge.
- Neck management is a critical component in the oncologic control of these tumors.
Purpose of the Study:
- To evaluate the impact of neck dissection on local-regional control in high-grade salivary gland cancers.
- To determine the optimal surgical approach for neck management in these malignancies.
Main Methods:
- Retrospective review of 18 patients with high-grade salivary gland malignancies treated between 1986 and 1997.
- Analysis of treatment modalities including neck dissection, supraomohyoid neck dissection (SOMH), and no neck treatment.
- Correlation of neck treatment with local-regional control outcomes.
Main Results:
- No significant difference in local-regional control was observed between patients who underwent neck dissection and those who did not.
- Prophylactic total neck dissection did not demonstrate an impressive improvement in local-regional control.
- Supraomohyoid neck dissection (SOMH) was found to be feasible for submandibular gland cancer cases without positive lymph nodes.
Conclusions:
- Prophylactic neck dissection is not routinely indicated for high-grade salivary gland carcinomas.
- Total neck dissection should be reserved for cases with clinically evident neck metastasis.
- Supraomohyoid neck dissection (SOMH) represents a viable option for select submandibular gland cancers.

